Table 2

Correlation of nuclear beta-catenin expression in SLN(s) with clinicopathological characteristics

Characteristics

Nuclear beta-catenin expression

P*


n

≤ 50%

> 50%


Gender

Male

247

178

69

0.745

Female

108

76

32

Age

≤ 55

54

15

39

< 0.001

> 55

301

239

62

Tumour localization

Rectum

203

145

58

0.954

Colon

152

109

43

Tumour size (cm)

≤ 5

120

90

30

0.303

≤ 5

235

164

71

Type of tumour

Adenocarcinoma

299

221

78

< 0.001

Mucinous adenocarcinoma

31

11

20

Signet-ring cell carcinoma

16

14

2

Undifferentiated carcinoma

9

8

1

Tumour cell differentiation

Well/moderately differentiated

279

218

61

< 0.001

Poorly differentiated

76

36

40

Tumour invasion depth

T1

5

5

0

< 0.001

T2

63

56

7

T3

252

176

76

T4

35

17

18

Lymph node metastasis

< 4

123

100

23

0.003

≥ 4

232

154

78

Liver metastasis

Negative

262

231

31

< 0.001

Positive

93

23

70

TNM stage

I

5

5

0

< 0.001

II

20

20

0

III

237

206

31

IV

93

23

70


* P value is the result of χ2 test in the same factor, and < 0.05 is considered statistically significant.

Cheng et al. Diagnostic Pathology 2011 6:109   doi:10.1186/1746-1596-6-109

Open Data